Phase 3 Gastrointestinal Bleeding Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
Gastrointestinal BleedingIschemic StrokeCerebrovascular Disease+3 more
Hanyang University Guri Hospital1,524 enrolled24 locationsNCT07687706
Recruiting
Phase 3
Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction
Gastrointestinal BleedingAcute Myocardial Infarction (AMI)
Samsung Medical Center5,000 enrolled1 locationNCT07467213
Completed
Phase 3
A Phase III Randomised, Double-blind, Placebo-controlled Trial to Assess the Efficacy of Tranexamic Acid in Reducing the Blood Loss in Patients with Per-rectal Bleeding
lower gastrointestinal bleeding
John Hunter Hospital100 enrolled1 locationACTRN12611000865910